Literature DB >> 22718127

A high percentage of serum samples that test reactive by enzyme immunoassay for anti-Brucella antibodies are not confirmed by the standard tube agglutination test.

Matthew J Binnicker1, Elitza S Theel, Staci M Larsen, Robin Patel.   

Abstract

We describe a retrospective analysis of Brucella enzyme immunoassay (EIA) IgM and IgG results compared to those of the standard tube agglutination test (SAT). Among 1,091 samples tested, 104 (9.5%) and 24 (2.2%) sera were positive by IgM and IgG EIA, respectively. Supplemental testing by SAT showed that 82.7% (86/104) of IgM EIA-reactive samples and 54.2% (13/24) of IgG EIA-reactive samples were negative by SAT. Testing all EIA screen-reactive samples by SAT is required when evaluating patients for potential brucellosis. Due to the limitations of serology, culture remains the gold standard for detecting Brucella infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718127      PMCID: PMC3416085          DOI: 10.1128/CVI.00197-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  8 in total

1.  A comparison of Brucella IgG and IgM ELISA assays with agglutination methodology.

Authors:  Ryan J Welch; Christine M Litwin
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

2.  Performance characteristics of the Euroimmun enzyme-linked immunosorbent assay kits for Brucella IgG and IgM.

Authors:  Harry E Prince; Janice Lopez; Cindy Yeh; Joselita Tablante; Joseph Morgan; Beverly Kaneko; Paul Duffey
Journal:  Diagn Microbiol Infect Dis       Date:  2009-10       Impact factor: 2.803

3.  Laboratory-acquired brucellosis in Turkey.

Authors:  S Sayin-Kutlu; M Kutlu; O Ergonul; S Akalin; T Guven; Y Z Demiroglu; O Acicbe; M Akova
Journal:  J Hosp Infect       Date:  2012-02-25       Impact factor: 3.926

4.  Limitations of the standard agglutination test for detecting patients with Brucella melitensis bacteremia.

Authors:  Ari A Shemesh; Pablo Yagupsky
Journal:  Vector Borne Zoonotic Dis       Date:  2011-09-15       Impact factor: 2.133

5.  Comparison of the Brucella Standard Agglutination Test with the ELISA IgG and IgM in patients with Brucella bacteremia.

Authors:  Z A Memish; M Almuneef; M W Mah; L A Qassem; A O Osoba
Journal:  Diagn Microbiol Infect Dis       Date:  2002-10       Impact factor: 2.803

6.  Serological and molecular diagnosis of human brucellosis in Najran, Southwestern Saudi Arabia.

Authors:  Ahmed Morad Asaad; Jobran Miree Alqahtani
Journal:  J Infect Public Health       Date:  2012-04-06       Impact factor: 3.718

7.  Evaluation of serological tests for diagnosis of brucellosis.

Authors:  Ozan Pabuccuoglu; Talat Ecemis; Sibel El; Abdullah Coskun; Sinem Akcali; Tamer Sanlidag
Journal:  Jpn J Infect Dis       Date:  2011       Impact factor: 1.362

8.  Public health consequences of a false-positive laboratory test result for Brucella--Florida, Georgia, and Michigan, 2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-06-06       Impact factor: 17.586

  8 in total
  2 in total

1.  Detection of IgM antibrucella antibody in the absence of IgGs: a challenge for the clinical interpretation of brucella serology.

Authors:  Julián Solís García Del Pozo; Santiago Lorente Ortuño; Elena Navarro; Javier Solera
Journal:  PLoS Negl Trop Dis       Date:  2014-12-04

2.  Clinical Interpretation of Detection of IgM Anti-Brucella Antibody in the Absence of IgG and Vice Versa; a Diagnostic Challenge for Clinicians.

Authors:  Reem Al Jindan; Nida Saleem; Aamir Shafi; Sheikh Muhammad Amjad
Journal:  Pol J Microbiol       Date:  2019
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.